Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Antimicrob Agents Chemother ; 56(3): 1382-9, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22232280

RESUMEN

Analysis of the evolution of drug target genes under changing drug policy is needed to assist monitoring of Plasmodium falciparum drug resistance in the field. Here we genotype Pfcrt and Pfdmr1 of 700 isolates collected in French Guiana from 2000 (5 years after withdrawal of chloroquine) to 2008, i.e., the period when the artemether-lumefantrine combination was progressively introduced and mefloquine was abandoned. Gene sequencing showed fixation of the 7G8-type Pfcrt SMVNT resistance haplotype and near fixation of the NYCDY Pfdmr1 haplotype. Pfdmr1 gene copy number correlated with 50% inhibitory concentrations of mefloquine and halofantrine (r = 0.64 and 0.47, respectively, n = 547); its temporal changes paralleled changes in in vitro mefloquine susceptibility. However, the molecular parameters studied did not account for the regained in vitro susceptibility to chloroquine and showed a poor correlation with susceptibility to artemether, lumefantrine, or quinine. Identification of novel markers of resistance to these antimalarials is needed in this South American area.


Asunto(s)
Aminoquinolinas/uso terapéutico , Antimaláricos/uso terapéutico , Resistencia a Medicamentos/genética , Malaria Falciparum/tratamiento farmacológico , Proteínas de Transporte de Membrana/genética , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/genética , Plasmodium falciparum/genética , Proteínas Protozoarias/genética , Combinación Arteméter y Lumefantrina , Artemisininas/uso terapéutico , Cloroquina/administración & dosificación , Cloroquina/uso terapéutico , Combinación de Medicamentos , Etanolaminas/uso terapéutico , Evolución Molecular , Fluorenos/uso terapéutico , Guyana Francesa/epidemiología , Dosificación de Gen , Haplotipos , Humanos , Concentración 50 Inhibidora , Estudios Longitudinales , Malaria Falciparum/epidemiología , Malaria Falciparum/parasitología , Mefloquina/uso terapéutico , Pruebas de Sensibilidad Parasitaria , Fenantrenos/uso terapéutico , Plasmodium falciparum/efectos de los fármacos , Guías de Práctica Clínica como Asunto , Quinina/administración & dosificación , Quinina/uso terapéutico
2.
BMC Microbiol ; 9: 219, 2009 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-19832989

RESUMEN

BACKGROUND: Genetic evidence for diversifying selection identified the Merozoite Surface Protein1 block2 (PfMSP1 block2) as a putative target of protective immunity against Plasmodium falciparum. The locus displays three family types and one recombinant type, each with multiple allelic forms differing by single nucleotide polymorphism as well as sequence, copy number and arrangement variation of three amino acid repeats. The family-specific antibody responses observed in endemic settings support immune selection operating at the family level. However, the factors contributing to the large intra-family allelic diversity remain unclear. To address this question, population allelic polymorphism and sequence variant-specific antibody responses were studied in a single Senegalese rural community where malaria transmission is intense and perennial. RESULTS: Family distribution showed no significant temporal fluctuation over the 10 y period surveyed. Sequencing of 358 PCR fragments identified 126 distinct alleles, including numerous novel alleles in each family and multiple novel alleles of recombinant types. The parasite population consisted in a large number of low frequency alleles, alongside one high-frequency and three intermediate frequency alleles. Population diversity tests supported positive selection at the family level, but showed no significant departure from neutrality when considering intra-family allelic sequence diversity and all families combined. Seroprevalence, analysed using biotinylated peptides displaying numerous sequence variants, was moderate and increased with age. Reactivity profiles were individual-specific, mapped to the family-specific flanking regions and to repeat sequences shared by numerous allelic forms within a family type. Seroreactivity to K1-, Mad20- and R033 families correlated with the relative family genotype distribution within the village. Antibody specificity remained unchanged with cumulated exposure to an increasingly large number of alleles. CONCLUSION: The Pfmsp1 block2 locus presents a very large population sequence diversity. The lack of stable acquisition of novel antibody specificities despite exposure to novel allelic forms is reminiscent of clonal imprinting. The locus appears under antibody-mediated diversifying selection in a variable environment that maintains a balance between the various family types without selecting for sequence variant allelic forms. There is no evidence of positive selection for intra-family sequence diversity, consistent with the observed characteristics of the antibody response.


Asunto(s)
Anticuerpos Antiprotozoarios/sangre , Malaria Falciparum/epidemiología , Proteína 1 de Superficie de Merozoito/genética , Plasmodium falciparum/genética , Selección Genética , Adolescente , Adulto , Alelos , Animales , Niño , Preescolar , ADN Protozoario/genética , Estudios de Seguimiento , Frecuencia de los Genes , Genética de Población , Genotipo , Humanos , Lactante , Malaria Falciparum/inmunología , Plasmodium falciparum/inmunología , Polimorfismo Genético , Estaciones del Año , Senegal/epidemiología , Análisis de Secuencia de ADN , Estudios Seroepidemiológicos , Adulto Joven
3.
Malar J ; 8: 86, 2009 Apr 29.
Artículo en Inglés | MEDLINE | ID: mdl-19402894

RESUMEN

BACKGROUND: Several strategies are currently deployed in many countries in the tropics to strengthen malaria control toward malaria elimination. To measure the impact of any intervention, there is a need to detect malaria properly. Mostly, decisions still rely on microscopy diagnosis. But sensitive diagnosis tools enabling to deal with a large number of samples are needed. The molecular detection approach offers a much higher sensitivity, and the flexibility to be automated and upgraded. METHODS: Two new molecular methods were developed: dot18S, a Plasmodium-specific nested PCR based on the 18S rRNA gene followed by dot-blot detection of species by using species-specific probes and CYTB, a Plasmodium-specific nested PCR based on cytochrome b gene followed by species detection using SNP analysis. The results were compared to those obtained with microscopic examination and the "standard" 18S rRNA gene based nested PCR using species specific primers. 337 samples were diagnosed. RESULTS: Compared to the microscopy the three molecular methods were more sensitive, greatly increasing the estimated prevalence of Plasmodium infection, including P. malariae and P. ovale. A high rate of mixed infections was uncovered with about one third of the villagers infected with more than one malaria parasite species. Dot18S and CYTB sensitivity outranged the "standard" nested PCR method, CYTB being the most sensitive. As a consequence, compared to the "standard" nested PCR method for the detection of Plasmodium spp., the sensitivity of dot18S and CYTB was respectively 95.3% and 97.3%. Consistent detection of Plasmodium spp. by the three molecular methods was obtained for 83% of tested isolates. Contradictory results were mostly related to detection of Plasmodium malariae and Plasmodium ovale in mixed infections, due to an "all-or-none" detection effect at low-level parasitaemia. CONCLUSION: A large reservoir of asymptomatic infections was uncovered using the molecular methods. Dot18S and CYTB, the new methods reported herein are highly sensitive, allow parasite DNA extraction as well as genus- and species-specific diagnosis of several hundreds of samples, and are amenable to high-throughput scaling up for larger sample sizes. Such methods provide novel information on malaria prevalence and epidemiology and are suited for active malaria detection. The usefulness of such sensitive malaria diagnosis tools, especially in low endemic areas where eradication plans are now on-going, is discussed in this paper.


Asunto(s)
ADN Protozoario/sangre , Malaria/diagnóstico , Plasmodium/clasificación , Plasmodium/aislamiento & purificación , Reacción en Cadena de la Polimerasa/métodos , ARN Ribosómico 18S/genética , Animales , Citocromos b/genética , Cartilla de ADN , Sondas de ADN , Humanos , Malaria/parasitología , Microscopía , Datos de Secuencia Molecular , Plasmodium/genética , Plasmodium falciparum/clasificación , Plasmodium falciparum/genética , Plasmodium falciparum/aislamiento & purificación , Plasmodium malariae/clasificación , Plasmodium malariae/genética , Plasmodium malariae/aislamiento & purificación , Plasmodium ovale/clasificación , Plasmodium ovale/genética , Plasmodium ovale/aislamiento & purificación , Plasmodium vivax/clasificación , Plasmodium vivax/genética , Plasmodium vivax/aislamiento & purificación , Prevalencia , Sensibilidad y Especificidad , Especificidad de la Especie
4.
J Antimicrob Chemother ; 62(5): 921-8, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18682531

RESUMEN

OBJECTIVES: Chemoprophylaxis is recommended during pregnancy to reduce the risk of placental infection. However, in areas with increasing drug resistance, it can trigger selection of resistant parasites in the placenta and increase the frequency of placental malaria. The objective of this study was to analyse the selection of drug-resistant parasites in the placenta in an area where chloroquine was still recommended as prophylaxis. PATIENTS AND METHODS: We analysed the polymorphism of parasites from matched placental and venous blood samples at the time of delivery from women in Dakar. Polymorphism of the isolates was studied using nested PCR typing of MSA1 and MSA2 genes, and full sequence of PfCRT exon 2. RESULTS: Of 692 women recruited at delivery, 72 had placental malaria. Two Pfcrt exon 2 genotypes were found, and 86% of the placentas had monoallelelic CVIET infection compared with 39% that had peripheral blood infection. Mixed parasite populations of CVIET/CVMNK occurred in 53% of the peripheral blood samples but only in 7% of the infected placentas. This selection of CVIET in placenta was not related to a decreased polymorphism of the parasites, as a large diversity of MSA1 and MSA2 was found in both placenta and venous blood. This diversity confirms that a multiplicity of circulation isolates can occur at low parasite transmission. msp1 and msp2 genotyping revealed mostly distinct populations of parasites in venous and placental blood. CONCLUSIONS: These data suggest that, even in low transmission areas, diverse parasite populations can accumulate in the placenta during pregnancy despite strong selection at the PfCRT locus due to chemoprophylaxis with chloroquine.


Asunto(s)
Resistencia a Medicamentos , Frecuencia de los Genes , Malaria Falciparum/parasitología , Proteínas de Transporte de Membrana/genética , Placenta/parasitología , Plasmodium falciparum/genética , Proteínas Protozoarias/genética , Adolescente , Adulto , Animales , Antígenos de Protozoos/genética , Sangre/parasitología , Quimioprevención/métodos , Niño , Cloroquina/uso terapéutico , ADN Protozoario/química , ADN Protozoario/genética , Femenino , Humanos , Malaria Falciparum/epidemiología , Proteína 1 de Superficie de Merozoito/genética , Plasmodium falciparum/aislamiento & purificación , Reacción en Cadena de la Polimerasa , Embarazo , Mujeres Embarazadas , Senegal/epidemiología , Análisis de Secuencia de ADN
5.
Malar J ; 6: 164, 2007 Dec 17.
Artículo en Inglés | MEDLINE | ID: mdl-18086297

RESUMEN

BACKGROUND: The antimalarial drug atovaquone specifically targets Plasmodium falciparum cytochrome b (Pfcytb), a mitochondrial gene with uniparental inheritance. Cases of resistance to atovaquone associated with mutant Pfcytb have been reported, justifying efforts to better document the natural polymorphism of this gene. To this end, a large molecular survey was conducted in several malaria endemic areas where atovaquone was not yet in regular use. METHODS: The polymorphism of the Pfcytb was analysed by direct sequencing of PCR products corresponding to the full length coding region. Sequence was generated for 671 isolates originating from three continents: Africa (Senegal, Ivory Coast, Central African Republic and Madagascar), Asia (Cambodia) and South America (French Guiana). RESULTS: Overall, 11 polymorphic sites were observed, of which eight were novel mutations. There was a large disparity in the geographic distribution of the mutants. All isolates from Senegal, Central African Republic and Madagascar displayed a Camp/3D7 wild type Pfcytb sequence, as did most samples originating from Cambodia and Ivory Coast. One synonymous (t759a at codon V253V) and two non-synonymous (t553g and a581g at codons F185V and H194R, respectively) singletons were detected in Ivory Coast. Likewise, two synonymous (a126t and c793t at codons -T42T and L265L, respectively) singletons were observed in Cambodia. In contrast, seven mutated sites, affecting seven codons and defining four mutant haplotypes were observed in French Guiana. The wild type allele was observed in only 14% of the French Guiana isolates. The synonymous c688t mutation at position L230L was highly prevalent; the most frequent allele was the c688t single mutant, observed in 84% of the isolates. The other alleles were singletons (a126t/a165c, a4g/a20t/a1024c and a20t/t341c/c688t corresponding to T42T/S55S, N2D/N71I/I342L, N71I/L114S/L230L, respectively" please replace with ' corresponding to T42T/S55S, N2D/N71I/I342L and N71I/L114S/L230L, respectively). The codon 268 polymorphisms associated with atovaquone resistance were not observed in the panel the isolates studied. Overall, the wild type PfCYTb protein isoform was highly predominant in all study areas, including French Guiana, suggesting stringent functional constraints. CONCLUSION: These data along with previously identified Pfcytb field polymorphisms indicate a clustering of molecular signatures, suggesting different ancestral types in South America and other continents. The absence of mutations associated with most atovaquone-proguanil clinical failures indicates that the atovaquone-proguanil association is an interesting treatment option in the study areas.


Asunto(s)
Citocromos b/genética , Malaria Falciparum/patología , Plasmodium falciparum/genética , Polimorfismo Genético , África , Sustitución de Aminoácidos/genética , Animales , Asia , ADN Mitocondrial/genética , ADN Protozoario/genética , Resistencia a Medicamentos/genética , Humanos , Plasmodium falciparum/aislamiento & purificación , Análisis de Secuencia , América del Sur
6.
Lancet ; 366(9501): 1960-3, 2005 Dec 03.
Artículo en Inglés | MEDLINE | ID: mdl-16325698

RESUMEN

Artemisinin derivatives are an essential component of treatment against multidrug-resistant Plasmodium falciparum malaria. We aimed to investigate in-vitro resistance to artemisinin derivatives in field isolates. In-vitro susceptibility of 530 P falciparum isolates from three countries (Cambodia, French Guiana, and Senegal) with different artemisinin use was assessed with an isotopic microtest. Artemether IC50 up to 117 and 45 nmol/L was seen in French Guiana and Senegal, respectively. DNA sequencing in a subsample of 60 isolates lends support to SERCA-PfATPase6 as the target for artemisinins. The S769N PfATPase6 mutation, noted exclusively in French Guiana, was associated with raised (>30 nmol/L) artemether IC50s (p<0.0001, Mann-Whitney). All resistant isolates came from areas with uncontrolled use of artemisinin derivatives. This rise in resistance indicates the need for increased vigilance and a coordinated and rapid deployment of drug combinations.


Asunto(s)
Antimaláricos/farmacología , Artemisininas/farmacología , Resistencia a Múltiples Medicamentos/genética , Plasmodium falciparum/efectos de los fármacos , Mutación Puntual/genética , Animales , Arteméter , Genotipo , Humanos , Pruebas de Sensibilidad Parasitaria/métodos , Plasmodium falciparum/genética , Plasmodium falciparum/aislamiento & purificación
7.
Malar J ; 5: 34, 2006 Apr 26.
Artículo en Inglés | MEDLINE | ID: mdl-16638153

RESUMEN

BACKGROUND: Because of its dramatic public health impact, Plasmodium falciparum resistance to chloroquine (CQ) has been documented early on. Chloroquine-resistance (CQR) emerged in the late 1950's independently in South East Asia and South America and progressively spread over all malaria areas. CQR was reported in East Africa in the 1970's, and has since invaded the African continent. Many questions remain about the actual selection and spreading process of CQR parasites, and about the evolution of the ancestral mutant gene(s) during spreading. METHODS: Eleven clinical isolates of P. falciparum from Cambodia and 238 from Africa (Senegal, Ivory Coast, Bukina Faso, Mali, Guinea, Togo, Benin, Niger, Congo, Madagascar, Comoros Islands, Tanzania, Kenya, Mozambique, Cameroun, Gabon) were collected during active case detection surveys carried out between 1996 and 2001. Parasite DNA was extracted from frozen blood aliquots and amplification of the gene pfcrt exon 2 (codon 72-76), exon 4 and intron 4 (codon 220 and microsatellite marker) were performed. All fragments were sequenced. RESULTS: 124 isolates with a sensitive (c76/c220:CVMNK/A) haplotype and 125 isolates with a resistant c76/c220:CVIET/S haplotype were found. The microsatellite showed 17 different types in the isolates carrying the c76/c220:CVMNK/A haplotype while all 125 isolates with a CVIET/S haplotype but two had a single microsatellite type, namely (TAAA)3(TA)15, whatever the location or time of collection. CONCLUSION: Those results are consistent with the migration of a single ancestral pfcrt CQR allele from Asia to Africa. This is related to the importance of PFCRT in the fitness of P. falciparum point out this protein as a potential target for developments of new antimalarial drugs.


Asunto(s)
Antimaláricos/farmacología , Cloroquina/farmacología , Malaria Falciparum/transmisión , Proteínas de la Membrana/genética , Plasmodium falciparum/efectos de los fármacos , Plasmodium falciparum/genética , África/epidemiología , Alelos , Animales , Secuencia de Bases , Cambodia/epidemiología , ADN Protozoario/análisis , Resistencia a Medicamentos/genética , Haplotipos , Humanos , Malaria Falciparum/epidemiología , Malaria Falciparum/parasitología , Proteínas de la Membrana/química , Proteínas de Transporte de Membrana , Repeticiones de Microsatélite , Datos de Secuencia Molecular , Proteínas Protozoarias
8.
Immunol Lett ; 84(1): 9-16, 2002 Oct 21.
Artículo en Inglés | MEDLINE | ID: mdl-12161278

RESUMEN

Several mechanisms have been proposed for explaining the protection of young children with hemoglobin AS from severe Plasmodium falciparum malaria. In a previous study carried out in Gabon, we have shown an association between hemoglobin AS carriage and a greater P. falciparum infection complexity. In the present study, we have investigated the presence and fine specificity of merozoite surface protein 2 (MSP2) reactive antibodies using different peptides covering conserved and polymorphic regions (Blocks 1-3) of P. falciparum MSP2 molecules. A cross-sectional study was conducted in the city of Bakoumba (Gabon), where malaria is hyperendemic with perennial P. falciparum transmission. Among the 641 children included, 135 were heterozygous for the sickle cell trait (HbAS). There was no significant difference in age distribution (mean age: 5 years, 0.5-11 years) and sex ratio in both hemoglobin groups (HbAA vs. HbAS). Blood group O was, however, associated with the sickle cell trait (P=0.02). P. falciparum isolates obtained from children with HbAS had a trend to higher infection complexity before the age of 5 years. Plasma samples were tested for the presence of antibodies to the different MSP2 peptides. Total IgG antibodies with a predominant reactivity against the FC27 type (the predominant P. falciparum MSP2 genotype) were found in serum samples from both groups. The profile of the IgG subclasses varied according to the hemoglobin phenotype. IgG3 and IgG2 were predominantly detected in plasma samples from HbAS children, whereas mainly IgG3 was found in children with HbAA. The role of the high multiclonal carriage associated with high family-specific antibodies reactive to MSP2 in HbAS children with asymptomatic P. falciparum parasitism is discussed.


Asunto(s)
Anticuerpos Antiprotozoarios/sangre , Antígenos de Protozoos/inmunología , Inmunoglobulina G/sangre , Inmunoglobulina G/clasificación , Malaria Falciparum/complicaciones , Malaria Falciparum/inmunología , Plasmodium falciparum/inmunología , Proteínas Protozoarias/inmunología , Rasgo Drepanocítico/complicaciones , Rasgo Drepanocítico/inmunología , Secuencia de Aminoácidos , Animales , Anticuerpos Antiprotozoarios/clasificación , Antígenos de Protozoos/genética , Secuencia de Bases , Estudios de Casos y Controles , Niño , Preescolar , Estudios Transversales , ADN Protozoario/genética , Femenino , Gabón , Genes Protozoarios , Hemoglobina A/metabolismo , Hemoglobina Falciforme/metabolismo , Humanos , Lactante , Malaria Falciparum/parasitología , Masculino , Datos de Secuencia Molecular , Plasmodium falciparum/genética , Proteínas Protozoarias/genética , Rasgo Drepanocítico/parasitología
9.
Acta Trop ; 81(1): 33-46, 2002 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11755430

RESUMEN

The present study is the first to investigate Plasmodium falciparum merozoite surface protein 1 (MSP1) allele-specific humoral responses in residents of central Africa. In endemic areas, acquired immune responses to malaria are assumed to reflect the need to be infected with a large number of antigenically diverse parasite populations. In the work presented here, the relationship between antibody specificity and the infecting parasite genotype was investigated in asymptomatic subjects and patients with uncomplicated malaria in order to possibly clarify the relationship between anti-MSP1 block2 antibodies and clinical malaria. Overall isolates were typed by nested PCR using allele-specific primers of the P. falciparum MSP1 gene to identify the infecting parasite genotype. The K1 type was the predominant allelic family in both clinical groups. Polyinfection (number of isolates with more than one parasite genotype) and the complexity of infections (mean number of parasite genotype per infected subject) were higher in isolates from asymptomatic individuals. Total immunoglobulins G (IgG) responses to schizont crude extract antigens and to MSP1 variant-specific peptides were assessed by ELISA test. More than 90% of the sera reacted against schizont extract, whatever the clinical group and the K1 seroprevalence was the highest in both clinical groups. Our results showed an age-dependence in the number of different variants of MSP1 block2 recognised by serum. Indeed, isolates from older (>14 years) subjects showed lower multiplicity of infection and higher was the mean number of different MSP1 variants recognised by their serum. This corresponded to the age reported for the acquisition of anti-parasite immunity under high malaria endemicity. The contribution of variant-specific immunity in asymptomatic malaria infections is discussed.


Asunto(s)
Anticuerpos Antiprotozoarios/sangre , Malaria Falciparum/parasitología , Proteína 1 de Superficie de Merozoito/genética , Plasmodium falciparum/genética , Adolescente , Adulto , Alelos , Secuencia de Aminoácidos , Animales , Niño , Preescolar , Gabón , Variación Genética , Humanos , Inmunoglobulina G/sangre , Lactante , Malaria Falciparum/sangre , Masculino , Proteína 1 de Superficie de Merozoito/inmunología , Persona de Mediana Edad , Datos de Secuencia Molecular , Plasmodium falciparum/inmunología , Factores de Tiempo
10.
PLoS One ; 5(3): e9817, 2010 Mar 23.
Artículo en Inglés | MEDLINE | ID: mdl-20352101

RESUMEN

BACKGROUND: Transmission of malaria in West African urban areas is low and healthcare facilities are well organized. However, malaria mortality remains high. We conducted a survey in Dakar with the general objective to establish who died from severe malaria (SM) in urban areas (particularly looking at the age-groups) and to compare parasite isolates associated with mild or severe malaria. METHODOLOGY/PRINCIPAL FINDINGS: The current study included mild- (MM) and severe malaria (SM) cases, treated in dispensaries (n = 2977) and hospitals (n = 104), We analysed Pfdhfr/Pfcrt-exon2 and nine microsatellite loci in 102 matched cases of SM and MM. Half of the malaria cases recorded at the dispensaries and 87% of SM cases referred to hospitals, occurred in adults, although adults only accounted for 26% of all dispensary consultations. This suggests that, in urban settings, whatever the reason for this adult over-representation, health-workers are forced to take care of increasing numbers of malaria cases among adults. Inappropriate self treatment and mutations in genes associated with drug resistance were found associated with SM in adults. SM was also associated with a specific pool of isolates highly polymorphic and different from those associated with MM. CONCLUSION: In this urban setting, adults currently represent one of the major groups of patients attending dispensaries for malaria treatment. For these patients, despite the low level of transmission, SM was associated with a specific and highly polymorphic pool of parasites which may have been selected by inappropriate treatment.


Asunto(s)
Malaria/epidemiología , Malaria/parasitología , Plasmodium falciparum/genética , Polimorfismo Genético , Tetrahidrofolato Deshidrogenasa/genética , Adolescente , Adulto , Animales , Niño , Femenino , Humanos , Desequilibrio de Ligamiento , Malaria/mortalidad , Masculino , Repeticiones de Microsatélite , Persona de Mediana Edad , Mutación , Senegal , Población Urbana
11.
PLoS One ; 5(2): e9424, 2010 Feb 25.
Artículo en Inglés | MEDLINE | ID: mdl-20195531

RESUMEN

Artemisinin, a thapsigargin-like sesquiterpene has been shown to inhibit the Plasmodium falciparum sarco/endoplasmic reticulum calcium-ATPase PfSERCA. To collect baseline pfserca sequence information before field deployment of Artemisinin-based Combination therapies that may select mutant parasites, we conducted a sequence analysis of 100 isolates from multiple sites in Africa, Asia and South America. Coding sequence diversity was large, with 29 mutated codons, including 32 SNPs (average of one SNP/115 bp), of which 19 were novel mutations. Most SNP detected in this study were clustered within a region in the cytosolic head of the protein. The PfSERCA functional domains were very well conserved, with non synonymous mutations located outside the functional domains, except for the S769N mutation associated in French Guiana with elevated IC(50) for artemether. The S769N mutation is located close to the hinge of the headpiece, which in other species modulates calcium affinity and in consequence efficacy of inhibitors, possibly linking calcium homeostasis to drug resistance. Genetic diversity was highest in Senegal, Brazil and French Guiana, and few mutations were identified in Asia. Population genetic analysis was conducted for a partial fragment of the gene encompassing nucleotide coordinates 87-2862 (unambiguous sequence available for 96 isolates). This supported a geographic clustering, with a separation between Old and New World samples and one dominant ancestral haplotype. Genetic drift alone cannot explain the observed polymorphism, suggesting that other evolutionary mechanisms are operating. One possible contributor could be the frequency of haemoglobinopathies that are associated with calcium dysregulation in the erythrocyte.


Asunto(s)
ATPasas Transportadoras de Calcio/genética , Variación Genética , Plasmodium falciparum/genética , Proteínas Protozoarias/genética , África , Américas , Secuencia de Aminoácidos , Animales , Antimaláricos/farmacología , Artemisininas/farmacología , Asia , Sitios de Unión/genética , ADN Protozoario/química , ADN Protozoario/genética , Resistencia a Medicamentos/genética , Geografía , Humanos , Malaria Falciparum/parasitología , Datos de Secuencia Molecular , Mutación Missense , Pruebas de Sensibilidad Parasitaria , Filogenia , Plasmodium falciparum/clasificación , Plasmodium falciparum/efectos de los fármacos , Polimorfismo de Nucleótido Simple , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido , Especificidad de la Especie
12.
PLoS One ; 2(1): e139, 2007 Jan 03.
Artículo en Inglés | MEDLINE | ID: mdl-17206274

RESUMEN

BACKGROUND: Inadequate treatment practices with antimalarials are considered major contributors to Plasmodium falciparum resistance to chloroquine, pyrimethamine and sulfadoxine. The longitudinal survey conducted in Dielmo, a rural Senegalese community, offers a unique frame to explore the impact of strictly controlled and quantified antimalarial use for diagnosed malaria on drug resistance. METHODOLOGY/PRINCIPAL FINDINGS: We conducted on a yearly basis a retrospective survey over a ten-year period that included two successive treatment policies, namely quinine during 1990-1994, and chloroquine (CQ) and sulfadoxine/pyrimethamine (SP) as first and second line treatments, respectively, during 1995-1999. Molecular beacon-based genotyping, gene sequencing and microsatellite analysis showed a low prevalence of Pfcrt and Pfdhfr-ts resistance alleles of Southeast Asian origin by the end of 1994 and their effective dissemination within one year of CQ and SP implementation. The Pfcrt resistant allele rose from 9% to 46% prevalence during the first year of CQ reintroduction, i.e., after a mean of 1.66 CQ treatment courses/person/year. The Pfdhfr-ts triple mutant rose from 0% to 20% by end 1996, after a mean of 0.35 SP treatment courses/person in a 16-month period. Both resistance alleles were observed at a younger age than all other alleles. Their spreading was associated with enhanced in vitro resistance and rapidly translated in an increased incidence of clinical malaria episodes during the early post-treatment period. CONCLUSION/SIGNIFICANCE: In such a highly endemic setting, selection of drug-resistant parasites took a single year after drug implementation, resulting in a rapid progression of the incidence of clinical malaria during the early post-treatment period. Controlled antimalarial use at the community level did not prevent dissemination of resistance haplotypes. This data pleads against reintroduction of CQ in places where resistant allele frequency has dropped to a very low level after CQ use has been discontinued, unless drastic measures are put in place to prevent selection and spreading of mutants during the post-treatment period.


Asunto(s)
Antimaláricos , Resistencia a Medicamentos , Malaria Falciparum/tratamiento farmacológico , Plasmodium falciparum/efectos de los fármacos , Adolescente , Adulto , Animales , Antimaláricos/farmacología , Antimaláricos/uso terapéutico , Niño , Preescolar , Cloroquina/farmacología , Cloroquina/uso terapéutico , Resistencia a Medicamentos/genética , Femenino , Genotipo , Humanos , Malaria Falciparum/epidemiología , Masculino , Proteínas de Transporte de Membrana/genética , Repeticiones de Microsatélite , Pruebas de Sensibilidad Parasitaria , Plasmodium falciparum/genética , Plasmodium falciparum/fisiología , Embarazo , Proteínas Protozoarias/genética , Pirimetamina/farmacología , Pirimetamina/uso terapéutico , Estudios Retrospectivos , Senegal/epidemiología , Análisis de Secuencia de ADN , Sulfadoxina/farmacología , Sulfadoxina/uso terapéutico , Tetrahidrofolato Deshidrogenasa/genética
13.
Antimicrob Agents Chemother ; 49(8): 3147-52, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16048916

RESUMEN

Cambodia is located in an area of resistance to multiple antimalarials and has been the first country to implement the systematic use of an artesunate-mefloquine combination as first-line treatment for Plasmodium falciparum malaria. Little is known, however, about the prevalence of resistance mutations within the natural parasite populations, impeding rational drug policy in this context. Using direct sequencing of PCR products, we have analyzed sequence polymorphism of the dihydrofolate reductase-thymidylate synthase, dihydropteroate synthetase, and multidrug resistance 1 genes in a large number of clinical P. falciparum isolates collected in various areas of Cambodia. This highlighted a 100% prevalence of haplotypes with multiple mutations in the target genes of antifolates after more than a decade without use of antifolates for malaria therapy. A high prevalence of mutations in Pfmdr1, including mutations associated with decreased in vitro susceptibility to mefloquine and quinine, was also observed. In addition, novel, low-frequency mutations were detected in Pfmdr1. Our findings show an alarming rate of multilocus resistance genotypes in Cambodia, requiring diligent surveillance and imposing limitations on possible future drug combinations.


Asunto(s)
Antimaláricos/farmacología , Resistencia a Múltiples Medicamentos/genética , Malaria Falciparum/epidemiología , Plasmodium falciparum/efectos de los fármacos , Proteínas Protozoarias/genética , Transportadoras de Casetes de Unión a ATP/genética , Animales , Cambodia/epidemiología , Dihidropteroato Sintasa/genética , Genes Protozoarios , Genotipo , Humanos , Malaria Falciparum/parasitología , Mutación , Pruebas de Sensibilidad Parasitaria , Plasmodium falciparum/clasificación , Plasmodium falciparum/genética , Prevalencia , Tetrahidrofolato Deshidrogenasa/genética , Timidilato Sintasa/genética
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda